The Institut Català de la Salut (Catalan Health Institute, ICS) is the largest provider of public health services in Catalonia. It manages 8 hospitals, 6 of them university hospitals, and 288 primary care centres. Two of the university hospitals participate in TRANSLINK.
Bellvitge University Hospital (HUB) is located in the city of L’Hospitalet de Llobregat, in the southern part of the Health Region of Barcelona serving an estimated population of 1.300.000 inhabitants. ICS-HUB performs every year 30,000 major surgery interventions. Of these, around 100 per year involve the implantation of aortic biological prosthetic valves.
During the project the HUB along with HUVB will participate in survey study and will be offered to all the patients fulfilling the inclusion criteria from which ICS will have available 300 aortic biological prosthetic valves that are performed each year between both hospitals. Also the HUB will analyzed specific antibodies responsible for the BHV damage, and evaluate mechanisms for BHV damage and evaluate the possibility of prevent infections during an invasive surgery like valve replacement.
Contributors to TRANSLINK:
- Dr. Rafael Mañez, (ICS-HUB), Director of Critical Care Medicine at ICS-HUB.